Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
Plus de filtres











Gamme d'année
1.
Front Genet ; 13: 948228, 2022.
Article de Anglais | MEDLINE | ID: mdl-36160013

RÉSUMÉ

Variations in water salinity and other extrinsic factors have been shown to induce changes in feeding rhythms and growth in fish. However, it is unknown whether appetite-related hormones mediate these changes in Nile tilapia (Oreochromis niloticus), an important species for aquaculture in several countries. This study aimed to evaluate the expression of genes responsible for appetite regulation and genes related to metabolic and physiological changes in tilapia exposed to different salinities. Moreover, the study proposed to sequence and to characterize the cart, cck, and pyy genes, and to quantify their expression in the brain and intestine of the fish by quantitative polymerase chain reaction (qPCR). The animals were exposed to three salinities: 0, 6, and 12 parts per thousand (ppt) of salt for 21 days. Furthermore, lipid peroxidation, reactive oxygen species, DNA damage, and membrane fluidity in blood cells were quantified by flow cytometry. The results indicated an increased expression of cart, pyy, and cck and a decreased expression of npy in the brain, and the same with cck and npy in the intestine of fish treated with 12 ppt. This modulation and other adaptive responses may have contributed to the decrease in weight gain, specific growth rate, and final weight. In addition, we showed oxidative damage in blood cells resulting from increasing salinity. These results provide essential data on O. niloticus when exposed to high salinities that have never been described before and generate knowledge necessary for developing biotechnologies that may help improve the production of economically important farmed fish.

2.
IBRO Neurosci Rep ; 12: 228-239, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-35746965

RÉSUMÉ

Ghrelin is a stomach-derived peptide hormone that acts via the growth hormone secretagogue receptor (GHSR) and displays a plethora of neuroendocrine, metabolic, autonomic and behavioral actions. It has been proposed that some actions of ghrelin are exerted via the vagus nerve, which provides a bidirectional communication between the central nervous system and peripheral systems. The vagus nerve comprises sensory fibers, which originate from neurons of the nodose and jugular ganglia, and motor fibers, which originate from neurons of the medulla. Many anatomical studies have mapped GHSR expression in vagal sensory or motor neurons. Also, numerous functional studies investigated the role of the vagus nerve mediating specific actions of ghrelin. Here, we critically review the topic and discuss the available evidence supporting, or not, a role for the vagus nerve mediating some specific actions of ghrelin. We conclude that studies using rats have provided the most congruent evidence indicating that the vagus nerve mediates some actions of ghrelin on the digestive and cardiovascular systems, whereas studies in mice resulted in conflicting observations. Even considering exclusively studies performed in rats, the putative role of the vagus nerve in mediating the orexigenic and growth hormone (GH) secretagogue properties of ghrelin remains debated. In humans, studies are still insufficient to draw definitive conclusions regarding the role of the vagus nerve mediating most of the actions of ghrelin. Thus, the extent to which the vagus nerve mediates ghrelin actions, particularly in humans, is still uncertain and likely one of the most intriguing unsolved aspects of the field.

3.
J Morphol ; 281(1): 55-67, 2020 01.
Article de Anglais | MEDLINE | ID: mdl-31782555

RÉSUMÉ

Goblet cells (GCs) and endocrine cells (ECs) play an important role in intestine physiology, and few studies currently exist for Amazonian fishes. This study aimed to quantify the distribution of GCs and ECs producing cholecystokinin-8 and neuropeptide Y, assessed by mucin histochemistry and peptides immunohistochemistry, in the intestine of two Amazonian species with different feeding habits Tambaqui (Colossosoma macropomum) and hybrid catfish (Pseudoplatystoma reticulatum × Leiarius marmoratus), an omnivore and carnivore, respectively. A systematic literature review correlating feeding habit and GC and EC distribution was also included to contribute to the comparative study. The results of this study provided novel information about the gut cells of Tambaqui and hybrid catfish. Both, GCs and ECs can be found sweeping the entire intestine of Tambaqui and hybrid catfish although the cells can be more concentrated in certain segments. The GCs and ECs in Tambaqui were more uniformly distributed in the midgut segments (T1, T2, and T3). Unlike, in hybrid catfish GCs were more concentrated in the hindgut (C4) and ECs mainly in the two midgut segments (C1 and C2) of hybrid catfish. Based on the comparison between Tambaqui, hybrid catfish, and other fishes in the literature review, we suggest that cell distribution can be partially explained by feeding habits, carnivorous vs. omnivorous.


Sujet(s)
Poissons-chats/génétique , Cellules endocrines/cytologie , Eau douce , Hybridation génétique , Intestins/cytologie , Animaux , Numération cellulaire , Cholécystokinine/métabolisme , Mucines/métabolisme , Neuropeptide Y/métabolisme , Fragments peptidiques/métabolisme , Revues systématiques comme sujet
4.
Obes Facts ; 11(6): 440-453, 2018.
Article de Anglais | MEDLINE | ID: mdl-30537704

RÉSUMÉ

OBJECTIVE: This study evaluated the effect of a protein, the isolated Trypsin Inhibitor (TTI) from Tamarindus indica L. seed, as a CCK secretagogue and its action upon food intake and leptin in obese Wistar rats. METHODS: Three groups of obese rats were fed 10 days one of the following diets: Standard diet (Labina®) + water; High Glycemic Index and Load (HGLI) diet + water or HGLI diet + TTI. Lean animals were fed the standard diet for the 10 days. Food intake, zoometric measurements, plasma CCK, plasma leptin, relative mRNA expression of intestinal CCK-related genes, and expression of the ob gene in subcutaneous adipose tissue were assessed. RESULTS: TTI decreased food intake but did not increase plasma CCK in obese animals. On the other hand, TTI treatment decreased CCK-1R gene expression in obese animals compared with the obese group with no treatment (p = 0.027). Obese animals treated with TTI presented lower plasma leptin than the non-treated obese animals. CONCLUSION: We suggest that TTI by decreasing plasma leptin may improve CCK action, regardless of its increase in plasma from obese rats, since food intake was lowest.


Sujet(s)
Anorexigènes/pharmacologie , Consommation alimentaire/effets des médicaments et des substances chimiques , Leptine/sang , Obésité , Protéines de légume/pharmacologie , Récepteur cholécystokinine/génétique , Tamarindus/composition chimique , Animaux , Anorexigènes/isolement et purification , Anorexigènes/usage thérapeutique , Régulation négative/effets des médicaments et des substances chimiques , Expression des gènes/effets des médicaments et des substances chimiques , Mâle , Obésité/sang , Obésité/traitement médicamenteux , Obésité/génétique , Protéines de légume/isolement et purification , Rats , Rat Wistar , Récepteur cholécystokinine/métabolisme , Sensation de satiété/effets des médicaments et des substances chimiques , Graines/composition chimique
5.
J Enzyme Inhib Med Chem ; 33(1): 334-348, 2018 Dec.
Article de Anglais | MEDLINE | ID: mdl-29322840

RÉSUMÉ

A trypsin inhibitor isolated from tamarind seed (TTI) has satietogenic effects in animals, increasing the cholecystokinin (CCK) in eutrophy and reducing leptin in obesity. We purified TTI (pTTI), characterised, and observed its effect upon CCK and leptin in obese Wistar rats. By HPLC, and after amplification of resolution, two protein fractions were observed: Fr1 and Fr2, with average mass of [M + 14H]+ = 19,594,690 Da and [M + 13H]+ = 19,578,266 Da, respectively. The protein fractions showed 54 and 53 amino acid residues with the same sequence. pTTI presented resistance to temperature and pH variations; IC50 was 2.7 × 10-10 mol.L-1 and Ki was 2.9 × 10-11 mol.L-1. The 2-DE revealed spots with isoelectric points between pH 5 and 6, and one near pH 8. pTTI action on leptin decrease was confirmed. We conclude that pTTI is a Kunitz trypsin inhibitor with possible biotechnological health-related application.


Sujet(s)
Agents antiobésité/pharmacologie , Modèles animaux de maladie humaine , Leptine/sang , Obésité/sang , Obésité/traitement médicamenteux , Peptides/pharmacologie , Protéines végétales/pharmacologie , Tamarindus/composition chimique , Animaux , Agents antiobésité/composition chimique , Agents antiobésité/isolement et purification , Relation dose-effet des médicaments , Mâle , Obésité/métabolisme , Peptides/composition chimique , Peptides/isolement et purification , Protéines végétales/composition chimique , Protéines végétales/isolement et purification , Rats , Rat Wistar , Graines/composition chimique , Relation structure-activité , Trypsine/métabolisme
6.
Gen Comp Endocrinol ; 237: 34-42, 2016 10 01.
Article de Anglais | MEDLINE | ID: mdl-27468955

RÉSUMÉ

The dourado, Salminus brasiliensis (Cuvier, 1816) is a freshwater piscivorous Characin native to South American rivers. Owing to the high quality of its flesh and its fast growth, it is the object of both capture fisheries and fish farming. However, very little is known about the endocrine regulation of feeding and metabolism of dourado. In this study, cDNAs for orexin, CART and CCK were isolated in dourado, and their mRNA tissue distributions examined. In order to assess the role of these peptides in the regulation of feeding of dourado, the effects of fasting and feeding on mRNA expression levels of orexin, CART and CCK in the brain as well as CCK in the intestine were assessed. Whereas orexin and CCK have widespread mRNA distributions in the brain and peripheral organs, CART seems to be mostly limited to the brain. Orexin brain expression increased with fasting and displayed periprandial changes, suggesting it is involved in both long- and short-term regulation of feeding and appetite. CART and CCK hypothalamic expressions were not affected by fasting, but displayed periprandial changes with post-feeding decreases, suggesting roles in short-term satiation. CCK expression in the anterior intestine was not affected by fasting and did not display periprandial changes. Overall, our results suggest that orexin, CART and CCK are involved in the physiology of feeding of dourado.


Sujet(s)
Appétit/physiologie , Characidae/génétique , Characidae/physiologie , ADN complémentaire/génétique , Jeûne/physiologie , Comportement alimentaire/physiologie , Régulation de l'expression des gènes , Animaux , Cholécystokinine/génétique , Cholécystokinine/métabolisme , Clonage moléculaire , ADN complémentaire/métabolisme , Analyse de profil d'expression de gènes , Hypothalamus/métabolisme , Protéines de tissu nerveux/génétique , Protéines de tissu nerveux/métabolisme , Orexines/génétique , Orexines/métabolisme , ARN messager/génétique , Réaction de polymérisation en chaine en temps réel , Distribution tissulaire
7.
Clinics ; Clinics;70(2): 136-143, 2/2015. tab, graf
Article de Anglais | LILACS | ID: lil-741419

RÉSUMÉ

OBJECTIVES: Seeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats. METHODS: A trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30-60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed. RESULTS: The trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water. CONCLUSION: The results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated. .


Sujet(s)
Humains , Infections à Escherichia coli/épidémiologie , Escherichia coli/enzymologie , bêta-Lactamases/métabolisme , Escherichia coli/pathogénicité , Fèces/microbiologie
8.
Psychol. neurosci. (Impr.) ; 6(3): 279-286, July-Dec. 2013.
Article de Anglais | LILACS | ID: lil-703091

RÉSUMÉ

Maternal behavior is regulated by several neurotransmitters, neuropeptides, and hormones. This mini-review focuses on the role of cholecystokinin (CCK), a neuropeptide and gut hormone best known as a satiety signal, in mediating maternal behavior. In addition to the role of CCK in the infant in mother-infant interactions, maternal CCK appears to also be important. We discuss maternal behavior research, mainly in rats, that has examined the effect of administering CCK to dams, CCK-opioid interactions, and maternal behavior in rats that lack CCK1 receptors. We discuss the possibility that CCK might play a role in neurological adjustments during pregnancy that ultimately influence behavioral adaptations by the offspring during lactation. Finally, we hypothesize that maternal CCK is also involved in maternal memory and reward...


Sujet(s)
Animaux , Rats , Cholécystokinine , Comportement maternel , Lactation
9.
Gene ; 531(2): 191-8, 2013 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-24035933

RÉSUMÉ

Sulfite oxidase (SO) deficiency is biochemically characterized by tissue accumulation and high urinary excretion of sulfite, thiosulfate and S-sulfocysteine. Affected patients present severe neurological symptoms and cortical atrophy, whose pathophysiology is still poorly established. Therefore, in the present work we investigated the in vitro effects of sulfite and thiosulfate on important parameters of energy metabolism in the brain of young rats. We verified that sulfite moderately inhibited the activity of complex IV, whereas thiosulfate did not alter any of the activities of the respiratory chain complexes. It was also found that sulfite and thiosulfate markedly reduced the activity of total creatine kinase (CK) and its mitochondrial and cytosolic isoforms, suggesting that these metabolites impair brain cellular energy buffering and transfer. In contrast, the activity of synaptic Na(+),K(+)-ATPase was not altered by sulfite or thiosulfate. We also observed that the inhibitory effect of sulfite and thiosulfate on CK activity was prevented by melatonin, reduced glutathione and the combination of both antioxidants, as well as by the nitric oxide synthase N(ω)-nitro-l-arginine methyl ester, indicating the involvement of reactive oxygen and nitrogen species in these effects. Sulfite and thiosulfate also increased 2',7'-dichlorofluorescin oxidation and hydrogen peroxide production and decreased the activity of the redox sensor aconitase enzyme, reinforcing a role for oxidative damage in the effects elicited by these metabolites. It may be presumed that the disturbance of cellular energy and redox homeostasis provoked by sulfite and thiosulfate contributes to the neurological symptoms and abnormalities found in patients affected by SO deficiency.


Sujet(s)
Aminoacidopathies congénitales/complications , Encéphalopathies métaboliques/étiologie , Encéphale/effets des médicaments et des substances chimiques , Métabolisme énergétique/effets des médicaments et des substances chimiques , Homéostasie/effets des médicaments et des substances chimiques , Sulfite oxidase/déficit , Sulfites/pharmacologie , Thiosulfates/pharmacologie , Aminoacidopathies congénitales/génétique , Aminoacidopathies congénitales/métabolisme , Aminoacidopathies congénitales/physiopathologie , Animaux , Encéphale/métabolisme , Encéphale/anatomopathologie , Encéphale/physiologie , Encéphalopathies métaboliques/génétique , Encéphalopathies métaboliques/métabolisme , Transport d'électrons/effets des médicaments et des substances chimiques , Transport d'électrons/génétique , Transport d'électrons/physiologie , Métabolisme énergétique/physiologie , Mâle , Oxydoréduction/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Sulfite oxidase/génétique , Sulfite oxidase/métabolisme , Sulfites/métabolisme , Thiosulfates/métabolisme
10.
Psychol. neurosci. (Impr.) ; 6(3): 279-286, 2013.
Article de Anglais | Index Psychologie - Revues | ID: psi-61623

RÉSUMÉ

Maternal behavior is regulated by several neurotransmitters, neuropeptides, and hormones. This mini-review focuses on the role of cholecystokinin (CCK), a neuropeptide and gut hormone best known as a satiety signal, in mediating maternal behavior. In addition to the role of CCK in the infant in mother-infant interactions, maternal CCK appears to also be important. We discuss maternal behavior research, mainly in rats, that has examined the effect of administering CCK to dams, CCK-opioid interactions, and maternal behavior in rats that lack CCK1 receptors. We discuss the possibility that CCK might play a role in neurological adjustments during pregnancy that ultimately influence behavioral adaptations by the offspring during lactation. Finally, we hypothesize that maternal CCK is also involved in maternal memory and reward.(AU)


Sujet(s)
Animaux , Rats , Cholécystokinine , Comportement maternel , Lactation
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE